Vident Advisory’s GoodRx Holdings GDRX Stock Holding History

Vident Advisory’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$618K	Buy	+214,489	New	+$545K	﹤0.01%	1251

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PTC

Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vident Advisory's GDRX Position: Q2 2026 in Review

Vident Advisory opened a new position in GoodRx Holdings (GDRX) in Q2 2026: 214,489 shares worth $618K. The stake represents ﹤0.01% of the portfolio and ranks #1251 among its holdings.

162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

Vident Advisory held 214,489 shares of GoodRx Holdings worth $618K as of Q2 2026.
GoodRx Holdings was a new Vident Advisory position in Q2 2026.
GoodRx Holdings made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1251 holding.
162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.